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Atopic dermatitis (AD) is the extremely complicated syndrome that various abnormalities develop in a heap. There are various
factors in patients for the onset and exacerbation of AD, including genetic cofactors of individuals, environmental factors, the
failure of the skin barrier function, unfavorable regulation of the immune system, and the hypersensitivity of sensory nerves. In
recent years, there have been many trials of the drug discovery that targets itch, because itch is one of the most serious clinical
symptoms of AD. The selection of the suitable animal model that represents the condition of patients, as well as innovative
analyzing protocols that can precisely evaluate itch, is indispensable for investigation of an eﬀective drug for AD. In the paper,
the unique spontaneous animal model for AD (NC/NgaTnd mice) and the novel quantiﬁcation system of the laboratory animals
that may bring a great progress in the future study of itch are outlined.
1.Introduction
Atopic dermatitis (AD) is a chronic and relapsing skin
disorder with allergic immune responses resulting in the
hyperproduction of IgE [1]. The most of the patients have
genetic cofactors promoting manifestation and/or family
history of allergic disorders, including anamnesis either or
some of bronchial asthma, allergic rhinitis, conjunctivitis.
Increased numbers of activated circulating CD4+ and CD8+
T cells and marked inﬁltration of CD4+ T cells into the
dermis are characteristic features of patients with AD. In
particular, T cells bearing the cutaneous lymphocyte antigen
with features of allergen-speciﬁc T cells of the Th2-type are
recruited. The initial phase of AD is dominated by Th2 type
T cells producing IL-4, IL-5, and IL-13; at the subsequent
chronic phase, the number of Th1 cells producing IFN-γ
increases. Not only T cells but also keratinocytes are capable
of aggravating the inﬂammatory reaction in the skin through
upregulated release of some cytokines and chemokines. Fur-
thermore, barrier dysfunction of atopic skins is likely to play
a pivotal role in the exacerbation of clinical conditions [2].
Contact or invasion of environmental antigens such as house
dust mites exacerbates clinical symptoms. Itch is one of the
most serious clinical symptoms of AD, and repeated itching-
scratching episodes may be greatly involved in acceleration
and severity of dermatitis [1, 3, 4]. Epidermal hyperplasia,
as well as inﬁltration of mononuclear cells and eosinophils,
and degranulation of mast cells at the aﬀected skins, is
the most typical pathological manifestations of AD [3].
Since the background is multifactorial and the underlying
predispositions is involved, the pathogenesis of AD is quite
complex. For understanding pathogenic pathways of AD,
suitable animal models are necessary, which may lead to the
development of new drugs with great beneﬁt for patients
with AD [5, 6].
2. Spontaneous Model for
HumanAD:NC/NgaTnd Mice
Microscopic features of skins obtained from NC/NgaTnd
mice raised in SPF (a) or conventional (b) circumstances.
NC/NgaTnd mice, an inbred strain originated from
Japanese fancy mice, spontaneously develop itchy dermatitis2 Journal of Biomedicine and Biotechnology
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Figure 1: NC/NgaTnd mice maintained in air-regulated SPF (a) or
air-unregulated conventional circumstances (b).
in an air-unregulated conventional circumstance from 6 to
8w e e k so fa g e( Figure 1). On the other hand, skin lesions
do not develop when they are raised in air-regulated speciﬁc
pathogen-free(SPF)conditions(Figure 1).Wehaveanalyzed
aspects manifested in NC/NgaTnd mice immunologically,
pathologically, dermatologically, and molecular biologically
and found that clinical symptoms in NC/NgaTnd mice are
quite similar to those found in human AD [7–9]. Thereafter,
as the ﬁrst spontaneous AD model mouse, NC/NgaTnd mice
attract attention from researchers of the world. NC/NgaTnd
mice are estimated as an appropriate animal model for the
screening of novel therapeutic agents for AD. In aﬀected
skins of NC/Nga mice, epidermal hyperplasia, increase and
degranulation of mast cells and recruitment of inﬂamma-
tory cells are remarkable (Figure 2). In addition, IL-4 is
produced in CD4+ T cells and mast cells, and Th2-speciﬁc
chemokines are overproduced [10], indicating that Th2-
type immune responses are upregulated. Exacerbation of
dermatitis relates to the increase of total IgE levels and
eosinophil numbers in circulation. Contents of ceramide in
skins are decreased in NC/NgaTnd mice before dermatitis
becomesremarkable,anditbecameclearthattransepidermal
water loss of aﬀected skins was promoted as a result [11].
The Itch-scratch cycle contributes to the development of
AD as a cofactor. Decreased production of semaphorin 3A
that has an activity to inhibit nerve growth factor-induced
sprouting of sensory neurons is recently reported in the skin
lesions of patients with AD and conventional NC/Nga mice
[12, 13], and repeated topical injection with recombinant
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Figure 2: Generation of mast cell-deﬁcient NC/NgaTnd mice.
N C / N g a T n dm i c ew i t hh e t e r o z y g o u s( a )a n dh o m o z y g o u s( b )f o r
the mast cell-deﬁcient Wsh gene mutation.
semaphorin 3A is eﬀective to improve the skin lesions of
conventional NC/Nga mice [13]. More recently, we have
demonstrated that thymic stromal lymphopoietin released
from keratinocytes of the skin lesions contributes to the
early stage of AD in NC/NgaTnd mice and peroxisome
proliferators activated receptors gamma activation down-
regulates the onset of AD via inhibition of dendritic cell
functions activated by thymic stromal lymphopoietin [14].
Researchers have to be careful because there are some
sublines of the NC strain that rarely develops AD spon-
taneously. When experiments in the conventional circum-
stances are not applicable, allergic dermatitis can be induced
by using repeated application protocols with haptens,
including FITC or picryl chloride. However, the hapten-
induced dermatitis is initiated by a Th1-mediated immune
response. Recently, atopic dermatitis-like skin lesions can be
reproduced by applying the extract of house dust mites to
SFP NC/NgaTnd mice as an ointment. Furthermore, hairless
NC/Nga mice are generated by using the toxin receptor-
mediated cell knockout (TRECK) method [15]. Hairless
NC/NgaTnd mice allows us to apply therapeutic reagentsJournal of Biomedicine and Biotechnology 3
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Figure 3: Microscopic features of skins obtained from NC/NgaTnd mice raised in SPF (a) or conventional (b) circumstances.
onto skins without shaving and to observe clinical symptoms
quite easily.
In our laboratory, NC/NgaTnd mice have been back-
crossed to speciﬁc gene-deﬁcient mice such as matrix
metalloprotease-9, Fc receptor γ chain, protease-activated
receptor 2 and succeeded in the construction of diﬀer-
ent congenic NC/NgaTnd mice deﬁcient for these genes.
Furthermore, mast cell-deﬁcient NC/NgaTnd mice have
been generated (Figure 3). Congenic gene manipulated
NC/NgaTnd mice will provide more precise information
concerning the involvement of certain genes in the develop-
ment and/or exacerbation of AD.
3. A Novel ScratchAnalyzingSystemfor
LaboratoryMice:SCLABA-Real
Reliable quantiﬁcation of scratching behavior in laboratory
mice is helpful for investigating itch mechanisms and for
developing new drugs for allergic dermatitis. We identiﬁed a
feasible parameter for quantiﬁcation of scratching behavior
in mice using a novel analyzing system, SCLABA-Real
(Figure 4).Althoughintradermalinjectionwithpruritogenic
reagents into mice, precise measurement and evaluation
of high-speed scratching behavior in mice have still been
complicated. SCLABA-Real enabled us to analyze scratching
behavior in real time without giving any kinds of stressful
operations to a mouse [16, 17]. The behavior of 4 mice
is simultaneously recorded with a high-speed digital vision
from the top of the exclusive cage placed on near-infrared
light. A SCLABA-Real software accurately detects the algo-
rithm that is speciﬁc for scratching behavior in mice and
records data in real time. Eﬀective antipruritic reagents can
be selected by an accurate evaluation of scratching behavior
in laboratory mice using a SCLABA-Real system.
Thenovelscratchanalyzingsystem,SCLABA-Real,calcu-
lates “frame-to-frame diﬀerence” that is a mouse’s migration
area per frame by capturing animal behavior at the rate
of 240 frames per second using the high-speed camera
containingimageprocessingsystem[16,17].Thiswholenew
system allows us to quantify the number and duration of
scratching behavior automatically by time-course analysis
of “frame-to-frame diﬀerence” and evaluate the degree of
itching from many directions.
The “frame-to-frame diﬀerence” analysis of the move-
ment is the uniquely method realized by using the special
camera in this system which can send images and the data
to the hard disk of a computer instantly through the video
server and LAN, which enable us to perform real-time and
accurate analysis of scratching only. Prolonged measurement
can be carried out because the stress on mice from the
preliminary treatment and the environment is excluded. The
recording platform has a built-in near-infrared light panel.
Scratchingbehaviorofmicecanberecordedinanaturalstate
using invisible near-infrared light. This system allows us to
evaluatescratchingbehaviornotonlyinthedaytimebutalso
in the nighttime and darkness. The timer that activates the
system automatically enables to start on analysis at night.
Although scratching behavior is the critical item for the
drugdevelopment,itsquantiﬁcationbyvisualcheckhasbeen
quite subjective. However, this innovative product provides
automatic analysis of scratching behavior in an objective and
accurate manner.
4. Remarks
AD is a quite complicated syndrome with many abnor-
malities, including genetic, environmental, immunological,
and dermatological cofactors. To select suitable animal
models for each research is particularly important to obtain
good outcomes. Therefore, researchers should know the
characteristics, including advantages and disadvantages, of
the model well. The spontaneous AD model, NC/NgaTnd
mice have provided valuable information concerning the
evaluation and selection of eﬀective new drugs and supple-
ments [18–21].
The drug development that targeted itch is prosperous,
but the past trials for quantiﬁcation of itch with a laboratory
animal have been failed. SCLABA-Real is an apparatus
of the extremely precise analyzing system for itch, that
is totally diﬀerent from conventional measuring systems.4 Journal of Biomedicine and Biotechnology
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Figure 4:Anovelscratchanalyzingsystem,SCLABA-Real.(a)Thehigh-speedcameracontainingimageprocessingsystemandtherecording
platformwithabuilt-innear-infraredlightpanelforreal-timequantiﬁcationofscratchingbehaviorofmice.(b)Realtimerecordandanalyze
window. (c) Analyzed data of scratching frequency and duration. (d) Validation window for each frame.
A spontaneous AD model NC/NgaTnd mice and a SCLABA-
Real system provide a possibility to develop the study of itch
in the next generation.
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